private:presagebiosciences
|
976548
|
May 31st, 2019 12:00AM
|
Presage Biosciences, Inc.
|
564
|
18.00
|
Open
|
Biotechnology
|
May 31st, 2019 01:53AM
|
May 31st, 2019 01:53AM
|
Presage works with oncology-focused pharmaceutical companies through strategic alliances that provide in vivo data to identify novel targets, advance drug candidates to the right indications, and discover novel drug combinations. Using our patented three-dimensional drug array platform, we are able to provide in-depth data sets on in vivo models far earlier in the drug development process and far more efficiently than otherwise possible. This enables Go/No-Go decisions to be based upon a foundation of in vivo data at all stages of drug development and asset prioritization. Basing such critical decisions on more clinically relevant in vivo models instead of fundamentally misleading in vitro data can save millions of research dollars and years in wasted effort.
|
Open
|
|
Open
|
530 Fairview Avenue North, Suite 1000
|
Seattle
|
WA
|
US
|
98109
|
|
Presage Biosciences
|
|
Pharmaceuticals & Biotechnology
|
private:presagebiosciences
|
976548
|
Feb 17th, 2018 12:00AM
|
Presage Biosciences, Inc.
|
459
|
16.00
|
Open
|
Biotechnology
|
Feb 17th, 2018 02:25PM
|
Feb 17th, 2018 02:25PM
|
Presage works with oncology-focused pharmaceutical companies through strategic alliances that provide in vivo data to identify novel targets, advance drug candidates to the right indications, and discover novel drug combinations. Using our patented three-dimensional drug array platform, we are able to provide in-depth data sets on in vivo models far earlier in the drug development process and far more efficiently than otherwise possible. This enables Go/No-Go decisions to be based upon a foundation of in vivo data at all stages of drug development and asset prioritization. Basing such critical decisions on more clinically relevant in vivo models instead of fundamentally misleading in vitro data can save millions of research dollars and years in wasted effort.
|
|
|
|
|
|
|
|
|
|
Presage Biosciences
|
|
Pharmaceuticals & Biotechnology
|
private:presagebiosciences
|
976548
|
Feb 16th, 2018 12:00AM
|
Presage Biosciences, Inc.
|
459
|
16.00
|
Open
|
Biotechnology
|
Feb 16th, 2017 08:15AM
|
Feb 16th, 2017 08:15AM
|
Presage works with oncology-focused pharmaceutical companies through strategic alliances that provide in vivo data to identify novel targets, advance drug candidates to the right indications, and discover novel drug combinations. Using our patented three-dimensional drug array platform, we are able to provide in-depth data sets on in vivo models far earlier in the drug development process and far more efficiently than otherwise possible. This enables Go/No-Go decisions to be based upon a foundation of in vivo data at all stages of drug development and asset prioritization. Basing such critical decisions on more clinically relevant in vivo models instead of fundamentally misleading in vitro data can save millions of research dollars and years in wasted effort.
|
|
|
|
|
|
|
|
|
|
Presage Biosciences
|
|
Pharmaceuticals & Biotechnology
|
private:presagebiosciences
|
976548
|
Feb 15th, 2018 12:00AM
|
Presage Biosciences, Inc.
|
459
|
16.00
|
Open
|
Biotechnology
|
Feb 15th, 2017 10:07AM
|
Feb 15th, 2017 10:07AM
|
Presage works with oncology-focused pharmaceutical companies through strategic alliances that provide in vivo data to identify novel targets, advance drug candidates to the right indications, and discover novel drug combinations. Using our patented three-dimensional drug array platform, we are able to provide in-depth data sets on in vivo models far earlier in the drug development process and far more efficiently than otherwise possible. This enables Go/No-Go decisions to be based upon a foundation of in vivo data at all stages of drug development and asset prioritization. Basing such critical decisions on more clinically relevant in vivo models instead of fundamentally misleading in vitro data can save millions of research dollars and years in wasted effort.
|
|
|
|
|
|
|
|
|
|
Presage Biosciences
|
|
Pharmaceuticals & Biotechnology
|
private:presagebiosciences
|
976548
|
Feb 14th, 2018 12:00AM
|
Presage Biosciences, Inc.
|
459
|
16.00
|
Open
|
Biotechnology
|
Feb 14th, 2017 01:50PM
|
Feb 14th, 2017 01:50PM
|
Presage works with oncology-focused pharmaceutical companies through strategic alliances that provide in vivo data to identify novel targets, advance drug candidates to the right indications, and discover novel drug combinations. Using our patented three-dimensional drug array platform, we are able to provide in-depth data sets on in vivo models far earlier in the drug development process and far more efficiently than otherwise possible. This enables Go/No-Go decisions to be based upon a foundation of in vivo data at all stages of drug development and asset prioritization. Basing such critical decisions on more clinically relevant in vivo models instead of fundamentally misleading in vitro data can save millions of research dollars and years in wasted effort.
|
|
|
|
|
|
|
|
|
|
Presage Biosciences
|
|
Pharmaceuticals & Biotechnology
|
private:presagebiosciences
|
976548
|
Feb 13th, 2018 12:00AM
|
Presage Biosciences, Inc.
|
459
|
16.00
|
Open
|
Biotechnology
|
Feb 13th, 2017 04:11PM
|
Feb 13th, 2017 04:11PM
|
Presage works with oncology-focused pharmaceutical companies through strategic alliances that provide in vivo data to identify novel targets, advance drug candidates to the right indications, and discover novel drug combinations. Using our patented three-dimensional drug array platform, we are able to provide in-depth data sets on in vivo models far earlier in the drug development process and far more efficiently than otherwise possible. This enables Go/No-Go decisions to be based upon a foundation of in vivo data at all stages of drug development and asset prioritization. Basing such critical decisions on more clinically relevant in vivo models instead of fundamentally misleading in vitro data can save millions of research dollars and years in wasted effort.
|
|
|
|
|
|
|
|
|
|
Presage Biosciences
|
|
Pharmaceuticals & Biotechnology
|
private:presagebiosciences
|
976548
|
Feb 12th, 2018 12:00AM
|
Presage Biosciences, Inc.
|
459
|
16.00
|
Open
|
Biotechnology
|
Feb 12th, 2017 04:15AM
|
Feb 12th, 2017 04:15AM
|
Presage works with oncology-focused pharmaceutical companies through strategic alliances that provide in vivo data to identify novel targets, advance drug candidates to the right indications, and discover novel drug combinations. Using our patented three-dimensional drug array platform, we are able to provide in-depth data sets on in vivo models far earlier in the drug development process and far more efficiently than otherwise possible. This enables Go/No-Go decisions to be based upon a foundation of in vivo data at all stages of drug development and asset prioritization. Basing such critical decisions on more clinically relevant in vivo models instead of fundamentally misleading in vitro data can save millions of research dollars and years in wasted effort.
|
|
|
|
|
|
|
|
|
|
Presage Biosciences
|
|
Pharmaceuticals & Biotechnology
|
private:presagebiosciences
|
976548
|
Feb 11th, 2018 12:00AM
|
Presage Biosciences, Inc.
|
459
|
16.00
|
Open
|
Biotechnology
|
Feb 11th, 2017 05:35AM
|
Feb 11th, 2017 05:35AM
|
Presage works with oncology-focused pharmaceutical companies through strategic alliances that provide in vivo data to identify novel targets, advance drug candidates to the right indications, and discover novel drug combinations. Using our patented three-dimensional drug array platform, we are able to provide in-depth data sets on in vivo models far earlier in the drug development process and far more efficiently than otherwise possible. This enables Go/No-Go decisions to be based upon a foundation of in vivo data at all stages of drug development and asset prioritization. Basing such critical decisions on more clinically relevant in vivo models instead of fundamentally misleading in vitro data can save millions of research dollars and years in wasted effort.
|
|
|
|
|
|
|
|
|
|
Presage Biosciences
|
|
Pharmaceuticals & Biotechnology
|
private:presagebiosciences
|
976548
|
Feb 10th, 2018 12:00AM
|
Presage Biosciences, Inc.
|
459
|
16.00
|
Open
|
Biotechnology
|
Feb 10th, 2017 06:43AM
|
Feb 10th, 2017 06:43AM
|
Presage works with oncology-focused pharmaceutical companies through strategic alliances that provide in vivo data to identify novel targets, advance drug candidates to the right indications, and discover novel drug combinations. Using our patented three-dimensional drug array platform, we are able to provide in-depth data sets on in vivo models far earlier in the drug development process and far more efficiently than otherwise possible. This enables Go/No-Go decisions to be based upon a foundation of in vivo data at all stages of drug development and asset prioritization. Basing such critical decisions on more clinically relevant in vivo models instead of fundamentally misleading in vitro data can save millions of research dollars and years in wasted effort.
|
|
|
|
|
|
|
|
|
|
Presage Biosciences
|
|
Pharmaceuticals & Biotechnology
|
private:presagebiosciences
|
976548
|
Feb 9th, 2018 12:00AM
|
Presage Biosciences, Inc.
|
459
|
16.00
|
Open
|
Biotechnology
|
Feb 9th, 2017 08:57AM
|
Feb 9th, 2017 08:57AM
|
Presage works with oncology-focused pharmaceutical companies through strategic alliances that provide in vivo data to identify novel targets, advance drug candidates to the right indications, and discover novel drug combinations. Using our patented three-dimensional drug array platform, we are able to provide in-depth data sets on in vivo models far earlier in the drug development process and far more efficiently than otherwise possible. This enables Go/No-Go decisions to be based upon a foundation of in vivo data at all stages of drug development and asset prioritization. Basing such critical decisions on more clinically relevant in vivo models instead of fundamentally misleading in vitro data can save millions of research dollars and years in wasted effort.
|
|
|
|
|
|
|
|
|
|
Presage Biosciences
|
|
Pharmaceuticals & Biotechnology
|